To understand the factors that regulate the early growth and development of immature erythroid progenitor cells, the burst-forming units-erythroid (BFU-E), it is necessary to have both highly purified target cells and a medium free of serum. When highly purified human blood BFU-E were cultured in a serum-free medium adequate for the growth of later erythroid progenitors, BFU-E would not grow even with the addition of recombinant human interleukin-3 (rlL-3), known to be essential for these cells. However, the addition of recombinant human stem cell factor (rSCF), which supports germ cell and pluripotential stem cell growth, stimulated BFU-E to grow equally well in serum-free as in serum-0 STUDY THE REGULATION of early erythropoie-T sis, it is desirable to have highly purified erythroid progenitor cells and a culture medium that does not contain serum because the latter may have unknown stimulators or inhibitors. We were able to generate highly purified human colony-forming units-erythroid (CFU-E) and to grow these cells in a medium without serum.'32 With this system it was possible to show that CFU-E do not require accessory cells for their development into red blood cells (RBCs), but do require direct interaction with erythropoietin (Epo) and with insulin-like growth factor I (IGF-I), or insulin, as the only hormones necessary for their growth.' Subsequently, attention turned to the control of burst-forming unitserythroid (BFU-E) development. We3 and others4-' were able to obtain highly purified human BFU-E and show an additional requirement for interleukin-3 (IL-3) or granulocyte-macrophage colony-stimulating factor (GM-CSF). It was also possible to show that only a small percentage of early, immature BFU-E had Epo receptors and that the frequency of Epo receptors per BFU-E was very low? As these BFU-E matured, during 72 hours of incubation in a serum-containing medium, Epo receptors then increased to a plateau value equivalent of that of the CFU-E and a marked dependence on Epo, which was not present initially, became apparent. At the same time, IL-3 dependence disappeared. However, it was not possible to grow highly purified BFU-E in the same serum-free medium developed for CFU-E, despite the addition of IL-3 and/or GM-CSF, suggesting a lack of additional factors in the medium that were necessary for BFU-E growth.
T sis, it is desirable to have highly purified erythroid progenitor cells and a culture medium that does not contain serum because the latter may have unknown stimulators or inhibitors. We were able to generate highly purified human colony-forming units-erythroid (CFU-E) and to grow these cells in a medium without serum.'32 With this system it was possible to show that CFU-E do not require accessory cells for their development into red blood cells (RBCs), but do require direct interaction with erythropoietin (Epo) and with insulin-like growth factor I (IGF-I), or insulin, as the only hormones necessary for their growth.' Subsequently, attention turned to the control of burst-forming unitserythroid (BFU-E) development. We3 and others4-' were able to obtain highly purified human BFU-E and show an additional requirement for interleukin-3 (IL-3) or granulocyte-macrophage colony-stimulating factor (GM-CSF). It was also possible to show that only a small percentage of early, immature BFU-E had Epo receptors and that the frequency of Epo receptors per BFU-E was very low? As these BFU-E matured, during 72 hours of incubation in a serum-containing medium, Epo receptors then increased to a plateau value equivalent of that of the CFU-E and a marked dependence on Epo, which was not present initially, became apparent. At the same time, IL-3 dependence disappeared. However, it was not possible to grow highly purified BFU-E in the same serum-free medium developed for CFU-E, despite the addition of IL-3 and/or GM-CSF, suggesting a lack of additional factors in the medium that were necessary for BFU-E growth.
Recently a newly discovered growth factor called stem cell factor (SCF) has been characteri~ed.*-'~ SCF was identified by its ability to stimulate primitive hematopoietic progenitors that were enriched in the bone marrow of mice treated with 5-fluor0uracil.~ The SCF has been purified, a human cDNA has been isolated, and a recombinant human SCF (rSCF) has been obtained.'SCF has been shown to be the product of the SI locus of the mouse,'O which is necessary for stem cell survival, and it has also been shown to stimulate hematopoietic stem cells, p r e -h e l l colony formation, mixed colony formation, and erythroid burst formation in the presence of other cells and additional containing medium. Limiting dilution studies showed that rSCF acts directly on the BFU-E that do not require accessory cells for growth. Furthermore, rSCF was necessary for BFU-E development during the initial 7 days of culture, until these cells reached the stage of the late progenitors, the colonyforming units-erythroid (CFU-E). These studies indicate that early erythropoiesis is dependent on the direct action of SCF that not only affects early stem cells but is continually necessary for the further development of committed erythroid progenitor cells until the CFU-E stage of maturation. o 1991 by The American Society of Hematology.
growth factors such as IL-3, IL-7, GM-CSF, and E p~. l ' -~~ However, whether rSCF acts directly on BFU-E, the stage of BFU-E development receptive to rSCF and the necessity for additional cellular or medium constituents is not known. We now present evidence that rSCF is required for continued BFU-E proliferation and maturation and that rSCF acts directly on BFU-E, without the need for accessory cells, for 7 days during BFU-E maturation, but is no longer necessary after development into the CFU-E is reached.
MATERIAL AND METHODS
Purification of human blood BFU-E. Blood (400 mL) was obtained after informed consent and BFU-E were highly purified by sequential density gradient centrifugation, depletion of sheep erythrocyte rosette-forming cells and Fc receptor positive cells, positive selection of anti-my lo-coated cells using immunomagnetic microspheres, overnight incubation to remove adherent cells, and negative selection of contaminant cells with a panel of nine monoclonal antibodies (MoAbs), as previously described.)
The BFU-E were plated in triplicate in 0.5 mL fibrin clots, at a concentration of 150 cellslml, in a serum-free medium that consisted of 50% Iscove's Modified Dulbecco's Medium (IMDM)/50% F-l2[HAM] supplemented with deionized, delipidated, dialyzed crystalline bovine serum albumin (C-BSA-3D) (10 mg/mL), iron-saturated transferrin (300 KglmL), lipid suspension (oleic acid, 5.6 FgImL; L-a-phosphatidyl Culture procedure for BFU-E. pooled human AB serum, 1% deionized BSA, 5 x lo-' mol/L 2-mercaptoethanol, 1.5 mmol/L aminocaproic acid, penicillinstreptomycin, 10 pg/mL insulin, 2 U/mL rEpo, 50 U/mL rIL-3, 2 mg/mL fibrinogen, 0.2 U/mL thrombin, and IMDM? After 15 days of incubation at 37°C in a 5% C0,/95% air atmosphere, the fibrin clots were fixed and stained with benzidine-hematoxylin16 and BFU-E were enumerated as previously de~cribed.'~
RESULTS
Using the serum-free medium that was developed for CFU-E: we incubated highly purified human blood BFU-E with increasing concentrations of rSCF in the presence or absence of rIL-3 ( Fig 1A) . Without rIL-3 and rSCF, very few erythroid bursts were formed, but even with the addition of 100 U/mL of rIL-3, only 12% of maximum burst formation occurred in the absence of rSCF and these bursts were very small (Table 1 ). However, with the addition of increasing concentrations of rSCF, erythroid burst formation exceeded that which occurred in a normal serumcontaining medium (P < .004), and was equal to the maximum number of erythroid bursts grown in a normal serum medium containing rSCF. The number of colonies increased from 7, without the addition of rSCF, to 30 at 50 ng/mL, with a plateau between 50 and 200 ng/mL of rSCF, and the size of the colonies increased from less than 500 cells/colony to more than 5,000 cells/colony at 100 ng/mL of rSCF (Table 1 ). The optimal concentration of rIL-3 (100 U/mL) is shown in Fig 1B. Optimal concentrations of crystalline BSA that had been deionized, delipidated, and dialyzed (C-BSA3D) (10 mg/mL), rEpo (2 U/mL), insulin (10 p,g/mL), transferrin (300 p,g/mL), and lipid suspension (10 pL/mL) were similar to those used for CFU-E' (Fig 1C  through H) . In the absence of serum, as little as 0.25% C-BSA3D provided growth that was equal in number and size of bursts to that of serum-containing medium (Fig 1C;  Table 1 ). As with CFU-E,' insulin was used in a pharmacologic concentration to replace a physiologic amount of IGF-I (2.5 ng/mL) because insulin binds to the IGF-I receptor and is much less expensive to use regularly. We next performed limiting dilution analysis'* of BFU-E growth in serum-free medium with rSCF and rIL-3, or in medium with serum (Fig 2) . When the percentage of nonresponder wells was plotted against the number of cells per well, both serum-free and serum-containing media showed straight lines going through the origin with no significant difference using x2 analysis (P > .9). This result indicated that both media are equivalent for single BFU-E growth and that highly purified BFU-E do not require accessory cells for their clonal development. Even though the BFU-E grew well when purified to 62% ? 5% (Fig l) , the effect of added cytokines might still occur through stimulation of remaining Effect of increasing concentrations of rSCF, rlL-3, and other components of serum-free medium on BFU-E growth. Highly purified human blood BFU-E were plated in 0.5 mL fibrin clots, at a concentration of 150 cells/mL. in a serum-free medium previously reported for CFU-E.2 with the addition of pure rSCF (25 ng/mL) and rlL-3 (I00 U/mL). Insulin was omitted when IGF-I was added and rlL-3 or rSCF was omitted in (A) or (8). respectively. Each point is the mean .tSD of triplicates after 15 days of incubation. The fibrin clots were fixed and strained with benzidine-hematoxylin'6 and BFU-E were enumerated as previously described." The lower shaded areas show the mean -tSD of triplicates with serum-containing medium? while the upper shaded areas show the mean -cSD of triplicates with serum-free medium and 25 ng/mL rSCF. These values were significantly different (P < .02). The figure represents two experiments in which the purity of the BFU-E was 62% 2 5% and 44% contaminant cells. However, the present experiments show that rSCF and rIL-3 are acting directly on the BFU-E because no other cells were necessary for development. If accessory cells were playing a role in BFU-E development,
3%.
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These data are from the experiments of Fig 1 and provide an estimate of the relative increase in size of the erythroid bursts with increasing concentrations of essential components after 15 days of incubation. Colony size I 500 is taken as 1 +; 5 1,000 as 2+; I 3,000 as 3+; I 5,000 as 4+; > 5,000 as 5+. BFU-E purity was 44% ? 3%.
Abbreviation: CS, colony size.
the lines would point away from the origin and then bend toward the origin as the B W -E were diluted to 100% negative wells while the remaining essential accessory cells continued to be diluted.
To investigate the dependency of normal human blood BFU-E on rSCF and rIL-3 during later stages of maturation, BFU-E cultures were initiated in serum-free medium without one, or the other, of these two cytokines. Limiting dilution analysis of BFU-E growth in serumcontaining medium ( 0 ) and serum-free medium with rSCF at 25 ng/mL (0). Highly purified human blood BFU-E were suspended in medium at concentrations of 20, 40, 80. and 160 cells/mL before aliquoting 50 pL into %-well flat-bottom tissue culture plates. After 15 days of incubation, the clots were fixed and stained by benzidinehematoxylin,'6 and the number of clots in which erythroid bursts did not develop were counted as BFU-E-negative wells. This number was plotted against the number of cells plated into the wells. Each point represents the values obtained from 60 wells. The purity of the BFU-E was 34% & 5%.
intervals (Fig 3) . The omission of rIL-3 for the first 24 hours of cell culture led to a 45% decline in BFU-E colonies and omission for 48 hours produced a 65% decline, indicating a marked dependence on rIL-3 during the first 48 hours of BFU-E culture. In contrast to the acute decline without rIL-3, BFU-E colony growth declined very slowly and steadily as rSCF was withheld over 1 week. In the presence of rIL-3, 80% of BFU-E formed erythroid bursts after an absence of rSCF for 48 hours, and 40% of the colonies were still present after an absence of rSCF for 96 hours, although The effect of delayed addition of rSCF or rlL-3 on blood BFU-E development in a serum-free medium. Purified human blood BFU-E were plated in 0.5 mL fibrin clots at 150 cells/mL with 100 U/mL rlL-3 ( 0 ) or 50 ng/mL rSCF (0) on day 1. At the indicated times, 0.2 mL of serum-free medium containing 35 ng rSCF ( 0 ) or 70 U rlL-3 (0) was overlaid on the clots. The cells were incubated for 14 days and then fixed and stained with benzidine-hematoxylin. 16 The number of erythroid bursts observed in clots plated on day 1 with both rSCF and rlL-3 was taken as 100% expression and each value is the mean ? SD of six replicates. The BFU-E purity was 50% & 6%.
For personal use only. on November 15, 2017. by guest www.bloodjournal.org From the size of the colonies became much smaller. The rSCF appears to enhance erythroid proliferation during the complete maturation sequence of BFU-E to CFU-E and to be essential for continued BFU-E development. Two-way analysis of variance'' indicated that delayed addition of rSCF, when compared with rIL-3, produced a significantly different effect (P < .01). In contrast to rIL-3 and rEpo, which act as viability factors preventing acute programmed cell rSCF has a more chronic effect with a loss of 10% to 15% of maximum erythroid burst formation every 24 hours it is withheld and appears to act in a different manner. In addition, the former cytokines have a very narrow window of target cell maturation stage for their effect~,~"while rSCF acts through a broad range of cellular development from multipotential germ cells and hematopoietic stem cells to single lineage erythroid progenitor cell^.^-'^
DISCUSSION
These experiments show a useful and reliable serum-free culture system that completely supports BFU-E development with an enhanced plating efficiency and proliferative capacity compared with serum-containing medium. In addition, it is clear that accessory cells are not necessary for BFU-E growth. This finding makes possible the determination of the essential ingredients for BFU-E development. Using this serum-free system, we found that BFU-E have an absolute requirement for rSCF in order to grow and develop. Almost no bursts were found in the absence of rSCF, while full cloning efficiency was attained at optimum plateau doses. In our hands, this is a key element that enables a medium without serum to nurture BFU-E growth and differentiation. With a serum-free medium and highly purified BFU-E we were able to show that rSCF acts directly on the BFU-E. Additionally, it is evident that rSCF is continually necessary for BFU-E development until the CFU-E stage of differentiation is reached. Thus, SCF not only stimulates early pluripotent hematopoietic stem cells, but is necessary for the further development of specialized hematopoietic progenitor cells down to the stage of maximum Epo sensitivity and dependence.
During this period of action, the SCF also needs additional cytokines to sustain its effect. While insulin or IGF-I appeared to have only a small effect on the number of bursts, their absence led to a 40% decrease in the size of the bursts (Table 1 ). This finding suggests that insulin and IGF-I mainly potentiated the proliferation of mature erythroid progenitor cells consistent with the previous demonstration of a requirement for insulin or IGF-I by CFU-E. In contrast to a previous report:' no effect of basic fibroblast growth factor was evident in this system with or without rSCF (Dai CH, Krantz SB, unpublished data, May, 1991). While BFU-E have been reported to grow in a serum-free medium without the addition of SCF," this might have been successful because of the use of a crude BSA preparation instead of the crystallized BSA used here.
At the early BFU-E level, IL-3 is essential for erythroid growth and maturation while at the CFU-E level Epo is necessa~y.'.~ Maintenance of viability is transferred from IL-3, which supports earlier cells with multiple potentials for differentiation into granulocytic, megakaryocytic, or erythroid progenitor cells, to more specific cytokines that regulate single lineages such as Epo for RBC production or granulocyte colony-stimulating factor (G-CSF) for granulocyte production," while SCF appears to maintain proliferation across the whole spectrum of development. The mechanism of this synergistic cooperation is not known, but it could involve interactive effects on receptor upregulation or mutual enhancement of signal transduction. With this BFU-E system, in which the cells are more plentiful than stem cells and the base of information is well characterized, further investigation is now possible into the biochemical mechanism of this interaction.
